Academic Journal

Polymyxins leading to nephrotoxicity

التفاصيل البيبلوغرافية
العنوان: Polymyxins leading to nephrotoxicity
المؤلفون: Lolla, Siddhartha, Uddin, Shaik Nayeem, Supriya, Chinta, Singh, Thakur Nikhil
المصدر: International Journal of Basic & Clinical Pharmacology; Vol. 12 No. 6 (2023): November-December 2023; 874-878 ; 2279-0780 ; 2319-2003
بيانات النشر: Medip Academy
سنة النشر: 2023
مصطلحات موضوعية: Gram-negative, Polymyxins, Colistimethate sodium, MCR genes, Monte Carlo simulations, Dosing
الوصف: Drug resistance gram-negative bacteria are the most hazardous type of germ because they cause life-threatening illnesses. Polymyxins are cyclic lipodecapeptide antibiotics that are effective against gram-negative bacteria like Acinetobacter, Pseudomonas, and other Enterobacteriaceae (such Klebsiella, Escherichia coli, and Serratia). Polymyxins kill bacteria by rupturing the bacterial outer membrane (OM). The main side effect of this antibiotic class is the development of kidney damage. Transposable genetic elements, such as MCR genes, can encode bacterial resistance to polymyxins. Colistin's prodrug is colistimethate sodium (CMS). Polymyxin dosage should be modified based on renal function. Polymyxins have demonstrated excellent clinical results, which have aided in the development of a better dosage regimen. Monte Carlo simulations were used to determine the most effective polymyxin dosages. Polymyxin resurgence has resulted in the eradication of multidrug resistant gram negative bacteria.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
Relation: https://www.ijbcp.com/index.php/ijbcp/article/view/5416/3610; https://www.ijbcp.com/index.php/ijbcp/article/view/5416
DOI: 10.18203/2319-2003.ijbcp20233202
الاتاحة: https://www.ijbcp.com/index.php/ijbcp/article/view/5416
https://doi.org/10.18203/2319-2003.ijbcp20233202
Rights: Copyright (c) 2023 International Journal of Basic & Clinical Pharmacology
رقم الانضمام: edsbas.FB902368
قاعدة البيانات: BASE
الوصف
DOI:10.18203/2319-2003.ijbcp20233202